Research Diagnosis Related Groups (DRG) level ICU LOS quality outcomes for University of Alabama Hospital located at 619 19Th St S, Birmingham, AL, 35249 & includes data from NPIs 1154435824
Dexur analyzed Q4 2018 (October to December 2018) Medicare claims data to benchmark ICU length of stay (LOS) outcomes for University of Alabama Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 3,184 | 3,021 | ||||||||||
| Surgical | 1,232 | 1,182 | ||||||||||
| Non Surgical | 1,952 | 1,839 | ||||||||||
| Cardiovascular | 619 | 599 | ||||||||||
| General Surgery | 473 | 440 | ||||||||||
| General Medicine | 444 | 388 | ||||||||||
| Neurology | 295 | 274 | ||||||||||
| Urology | 254 | 249 | ||||||||||
| Orthopedics | 250 | 248 | ||||||||||
| Gastroenterology & Endocrinology | 246 | 245 | ||||||||||
| Pulmonology | 185 | 176 | ||||||||||
| Oncology & Hematology | 176 | 166 | ||||||||||
| Obstetrics & Gynecology | 61 | 60 | ||||||||||
| Spine | 58 | 56 | ||||||||||
| Colorectal | 53 | 52 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 33 | 32 | ||||||||||
| Psychiatry & Mental Disorders | 20 | 20 | ||||||||||
| Dermatology | 17 | 16 |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Aortic And Heart Assist Procedures | ||||||||||||
| DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Hypertension | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
| Tracheostomy For Face, Mouth And Neck Diagnoses Or Laryngectomy | ||||||||||||
| Craniotomy With Major Device Implant Or Acute Complex Cns Pdx | ||||||||||||
| DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT | ||||||||||||
| Autologous Bone Marrow Transplant Or T-Cell Immunotherapy | ||||||||||||
| DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other O.R. Procedures For Injuries | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| Major Head And Neck Procedures | ||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
| Other Digestive System O.R. Procedures | ||||||||||||
| Pancreas, Liver And Shunt Procedures |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment | ||||||||||||
| Hiv With Major Related Condition | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma > 1 Hour | ||||||||||||
| DRG 083: TRAUMATIC STUPOR AND COMA, COMA >1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Other Kidney And Urinary Tract Procedures |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Disorders Of Biliary Tract |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||
| DRG 205: OTHER RESPIRATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pleural Effusion |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Digestive Malignancy | ||||||||||||
| DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chemotherapy | ||||||||||||
| DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
| Nervous System Neoplasms | ||||||||||||
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| Respiratory Neoplasms |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy | ||||||||||||
| Uterine And Adnexal Procedures For Non-Malignancy |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cervical Spinal Fusion | ||||||||||||
| DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | Alabama Total Hospitalizations (Oct 2018 to Dec 2018) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. ICU LOS | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures | ||||||||||||
| DRG 328: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |